IP Library Granted Patent US 8,999,424
Granted Patent B2
US 8,999,424 · App. 13/238,483 · Granted Apr 7, 2015

Performance enhancing composition and method of delivering nutrients

Inventors: Ralph Mario Ferrante (Upper Grandview, NY); Chad Kevin Cunningham (Tappan, NY)
Assignee: Advanced Bio Development, Inc.
A61K31/122A23L1/0002A23L1/0005A23L1/0017A23L1/09A23L1/304A23L1/30A23V2002/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,999,424
App. No.
13/238,483
Granted
Apr 7, 2015
Kind
B2
Abstract

An aqueous composition specifically adapted for supporting physical performance. The liquid composition comprises ribose, a saccharide such as glucose or dextrose, coenzyme Q10, ATP, caffeine, and D-pinitol in conjunction with minerals and electrolytes. The orally-consumed liquid composition may be sold in solid form, such as a powder, granulate, or tablet to be added to water or other fluid, or it may be sold as a shelf-stable ready-to-drink liquid. The liquid composition physiologically enhances essential energy stores and provides a supply of ingredients which support physiological generation and regeneration of ATP.

Claims (43)

1. A nutraceutical liquid composition consisting of:

a saccharide which is glucose or dextrose in the range of from 15 to 340 grams per liter of the liquid;

ribose in the range of from 25 to 85 grams per liter of the liquid;

coenzyme Q10 in the range of from 15 milligrams to 5 grams per liter of the liquid;

ATP disodium in the range of from 15 milligrams to 17 grams per liter of the liquid;

caffeine in the range of from 415 milligrams to 17 grams per liter of the liquid;

D-pinitol in the range of from 15 milligrams to 17 grams per liter of the liquid;

sodium in the range of from 15 milligrams to 5 grams per liter of the liquid;

potassium in the range of from 15 milligrams to 3.5 grams per liter of the liquid;

calcium in the range of from 15 milligrams to 2 grams per liter of the liquid;

magnesium in the range of from 15 milligrams to 2 grams per liter of the liquid;

a preservative;

an acidulant;

a flavoring agent;

a colorant; and

water or juice.

2. An individual serving of a nutraceutical composition consisting of:

3 gm ribose;

100 mg coenzyme Q10;

250 mg adenosine triphosphate (ATP) disodium;

70 mg caffeine;

30 mg D-pinitol;

12.5 gm dextrose or glucose;

180 mg trisodium citrate;

24 mg sodium benzoate;

164 mg monopotassium phosphate;

24 mg potassium sorbate;

500 mg citric acid;

215 mg calcium lactate;

210 mg magnesium lactate;

a flavoring agent; and

a colorant.

3. The composition according to claim 2 , wherein the composition is in the form of a tablet, powder, granulate, stick-pack, ready-to-dissolve concentrate, or a liquid formulation.

4. An individual serving of a nutraceutical composition consisting of:

(a) 3 gm ribose; 100 mg coenzyme Q10; 250 mg adenosine triphosphate (ATP) disodium; 70 mg caffeine; 30 mg D-pinitol; and 12.5 gm dextrose or glucose; and

(b) one or more components selected from the group consisting of:

sodium in the range of from 15 milligrams to 5 grams per liter of a ready-to-drink aqueous formulation of the composition;

potassium in the range of from 15 milligrams to 3.5 grams per liter of the ready-to-drink formulation;

calcium in the range of from 15 milligrams to 2 grams per liter of the ready-to-drink formulation;

magnesium in the range of from 15 milligrams to 2 grams per liter of the ready-to-drink formulation;

a preservative, an acidulant, a flavoring agent, a colorant, and combinations thereof.

5. The composition according to claim 4 , wherein the composition is formulated in an aqueous liquid.

6. The composition according to claim 4 , wherein the composition is in the form of a tablet, powder, granulate, stick-pack, or ready-to-dissolve concentrate.

Assignments (3)
SECURITY INTEREST Recorded Aug 25, 2022
From: ADVANCED BIO DEVELOPMENT, INC.
To: SILICON VALLEY BANK
Reel/Frame 060900/0812 →
CONVERSION OF LLC TO CORPORATION Recorded Oct 18, 2013
From: ADVANCED BIO DEVELOPMENT LLC
To: ADVANCED BIO DEVELOPMENT, INC.
Reel/Frame 031447/0296 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 21, 2011
From: FERRANTE, RALPH MARIO; CUNNINGHAM, CHAD KEVIN
To: ADVANCED BIO DEVELOPMENT LLC
Reel/Frame 026941/0815 →
Continuity (2)
Continuation In Part 12911925 · Oct 26, 2010
Related Publication 20120100120A1 · Apr 26, 2012